Monsanto Company (MON) Stake Decreased by MRJ Capital Inc.

MRJ Capital Inc. lowered its holdings in Monsanto Company (NYSE:MON) by 4.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,150 shares of the basic materials company’s stock after selling 600 shares during the quarter. MRJ Capital Inc.’s holdings in Monsanto were worth $1,695,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of MON. OZ Management LP purchased a new position in shares of Monsanto in the second quarter worth $242,786,000. BlackRock Inc. raised its stake in shares of Monsanto by 6.5% in the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after purchasing an additional 1,705,439 shares during the last quarter. York Capital Management Global Advisors LLC grew its holdings in shares of Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after acquiring an additional 1,506,057 shares during the period. Janus Henderson Group PLC grew its holdings in shares of Monsanto by 2,540.4% in the second quarter. Janus Henderson Group PLC now owns 1,491,324 shares of the basic materials company’s stock worth $176,515,000 after acquiring an additional 1,434,844 shares during the period. Finally, PSquared Asset Management AG grew its holdings in shares of Monsanto by 239.0% in the second quarter. PSquared Asset Management AG now owns 1,274,320 shares of the basic materials company’s stock worth $150,829,000 after acquiring an additional 898,395 shares during the period. Hedge funds and other institutional investors own 74.98% of the company’s stock.

In related news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the sale, the vice president now owns 38,600 shares in the company, valued at $4,718,850. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock worth $5,931,934 over the last quarter. 0.79% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2017/11/20/monsanto-company-mon-stake-decreased-by-mrj-capital-inc.html.

MON has been the subject of several research analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective for the company in a report on Monday, September 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a report on Friday, September 1st. Jefferies Group LLC reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a report on Friday, September 15th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $124.61.

Monsanto Company (MON) traded down $0.05 during midday trading on Monday, hitting $118.28. The stock had a trading volume of 302,203 shares, compared to its average volume of 1,938,844. The company has a market capitalization of $52,088.87, a price-to-earnings ratio of 21.40, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. Monsanto Company has a 1 year low of $100.29 and a 1 year high of $122.79.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The firm had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.07 earnings per share. sell-side analysts forecast that Monsanto Company will post 5.74 earnings per share for the current fiscal year.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit